Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

PURPOSE: The quality of life (QL) of advanced gastric cancer patients receiving irinotecan, folinic acid and 5-fluorouracil (5-FU) (IF arm) or cisplatin with 5-FU (CF arm) is presented. METHODS: Patients with measurable or evaluable advanced gastric cancer received IF weekly for 6/7 weeks or CF q4 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Curran, Desmond, Pozzo, Carmelo, Zaluski, Jerzy, Dank, Magdalena, Barone, Carlo, Valvere, Vahur, Yalcin, Suayib, Peschel, Christian, Wenczl, Miklós, Goker, Erdem, Bugat, Roland
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724642/
https://www.ncbi.nlm.nih.gov/pubmed/19568958
http://dx.doi.org/10.1007/s11136-009-9493-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724642/
https://www.ncbi.nlm.nih.gov/pubmed/19568958
http://dx.doi.org/10.1007/s11136-009-9493-z

Ejemplares similares